The development of functional NK cells within HSC‐engrafted NSG‐Tg(Hu‐IL15) mice creates a platform within immuno‐oncology for the in vivo study of NK cells in tumor–immune system interactions and testing novel immunotherapies mediated by NK cells. The gene discussed is IL15; the disease is neoplasm.